“It is essential to see medicines and healthcare as an economically and socially very profitable investment for Spain. An investment that generates very important benefits in […]

eleconomista.es In 2023, Spain overtook Germany as the country that initiated the most clinical trials and became the European leader. This is reflected in the report […]

Joint position on the Draft Bill on Medicines and Health ProductsThe proposed system of price regulation for off-patent medicines puts at risk the supply of medicines […]

The International Federation of Innovative Pharmaceutical Industries indicates that the sector invests almost 30% of its revenues in R&D, amounting to nearly 270 billion euros. Diarofarma.com […]

The Regional Minister of Health of Cantabria, César Pascual, inaugurates the 25th CAAC-Pharmaindustry Forum. ‘When we work together, not only do we promote research and biomedical […]

This research momentum means that one in three new medicines approved by Europe in 2024 was classified as an orphan drug. There are still many untreated […]

Getting to know new markets and establishing contacts with both potential customers and potential suppliers. Temperature control in pharmaceutical logistics is one of our pillars, as […]

The President of the Government meets for the second time with around twenty representatives of the national, European and global pharmaceutical industry to intensify public-private collaboration […]

For the first time, a study by the consultancy firm Afi has evaluated the impact of pharmaceutical companies from a dual perspective: the socio-economic value provided […]

37% of all clinical trials being developed in Spain are aimed at treating oncological diseases New drugs are having a direct impact on patient survival, according […]

More than 80 pupils from five schools learn about the process of getting medicines to patients: from R&D to clinical trials The “Bringing science to schools” […]

The European Medicines Agency approved a total of 114 medicines last year, 46 of which had a new active substance, seven more than the previous year. […]